Primary multidisciplinary management of extremity soft tissue sarcomas

Current Treatment Options in Oncology

Volumn 5, Issue 6, 2004, Pages 451-462

  Clarkson, Paul ^b   Ferguson, Peter C ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; GEMCITABINE; HEMOPOIETIC GROWTH FACTOR; IFOSFAMIDE; IMATINIB; MESNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; VINCRISTINE;

CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DERMATOFIBROSARCOMA PROTUBERANS; EWING SARCOMA; FUNCTIONAL ASSESSMENT; FUSION GENE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; INTERDISCIPLINARY COMMUNICATION; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; RADIATION DOSE; REVIEW; SOFT TISSUE SARCOMA; SURGICAL INFECTION; SYNOVIAL SARCOMA; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 9944220954     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-004-0034-2     Document Type: Review

References (76)

1. American Cancer Society: Cancer Facts, 2000. Accessible at www.cancer.org. Accessed September 17, 2004.
2. Gerrand CH, Bell RS, Wunder JS, et al.: The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer 2003, 97:485-492.
3. Davis AM, Devlin M, Griffin AM, et al.: Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study. Arch Phys Med Rehabil 1999, 80:615-618.
4. Karakousis CP, Zografos GC: Radiation therapy for high grade soft tissue sarcomas of the extremities treated with limb-preserving surgery. Eur J Surg Oncol 2002, 28: 31-436.
5. Karakousis CP, Driscoll DL: Treatment and local control of primary extremity soft tissue sarcomas. J Surg Oncol 1999, 71:155-161.
6. Popov P, Tukiainen E, Asko-Seljaavaara S, et al.: Soft tissue sarcomas of the lower extremity: surgical treatment and outcome. Eur J Surg Oncol 2000, 26:679-685.
7. Sadoski C, Suit H, Rosenberg AE, et al.: Pre-operative radiation, surgical margins and local control of extremity sarcomas of soft tissues. J Surg Oncol 1993, 52:223-230.
8. O'Sullivan B, Pisters PW: Staging and prognostic factor evaluation in soft tissue sarcoma. Surg Oncol Clin N Am 2003, 12:333-353.
9. Mankin HJ, Mankin CJ, Simon MA: The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996, 78:656-663.
10. Noria S, Davis A, Kandel R, et al.: Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am 1996, 78:650-655.
11. Bhangu A, Beard J, Grimer R: Should soft tissue sarcomas be treated at a specialist centre? Sarcoma 2004, 8:1-6.
12. Zagars CK, Ballo MT, Pisters PW, et al.: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients Cancer 2003, 97:2530-2543.
13. Pisters PW, Leung DH, Woodruff J, et al.: Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996, 14: 679-1689.
14. Cakir S, Dincbas FO, Uzel O, et al.: Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma Radiother Oncol 1995, 37:10-16.
15. Vraa S, Keller J, Nielsen OS, et al.: Prognostic factors in soft tissue sarcomas: the Aarhus experience. Eur J Cancer 1998, 34:1876-1882.
16. Coindre JM, Terrier P, Bui NB, et al.: Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996, 14:869-877.
17. Nielsen T, West R, Linn S, et al.: Molecular characterisation of soft tissue tumors: a gene expression study. Lancet 2002, 359:1301-1307.
18. Clark J, Rocques PJ, Crew AJ, et al.: Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994, 7:502-508.
19. Downing JR, Head DR, Parham DM, et al.: Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction Am J Pathol 1993, 143:1294-1300.
20. de Alava E, Panizo A, Antonescu CR, et al.: Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma. Am J Pathol 2000, 156:849-855.
21. de Alava E, Kawai A, Healey JH, et al.: EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998, 16:1248-1255.
22. Wunder JS, Healey JH, Davis AM, Brennan MF: A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer 2000, 88:2721-2730.
23. Kattan M, Leung D, Brennan MF: Postoperative Nomogram for 12-Year Sarcoma-Specific Death. J Clin Oncol 2002, 20: 91-796.
24. Kandel R, White L, Bell R, et al.: Histologic assessment of peritumoral edema in soft tissue sarcoma. in Connective Tissue Oncology Society Annual Meeting. Barcelona, Spain. 2003.
25. Simon MA, Enneking WF: The management of soft-tissue sarcomas of the extremities. J Bone Joint Surg Am 1976, 58: 17-327.
26. Suit H, Spiro IJ: Soft tissue sarcomas: radiation as a therapeutic option. Ann Acad Med Singapore 1996, 25: 55-861.
27. Spiro IJ, Rosenberg AE, Springfield D, Suit H: Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience Cancer Invest 1995, 13:86-95.
28. Gerrand CH, Wunder JS, Kandel RA, et al.: Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br 2001, 83:1149-1155.
29. Weitz J, Antonescu CR, Brennan MF: Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time J Clin Oncol 2003, 21:2719-2725.
30. Fuchs B, Davis AM, Wunder JS, et al.: Sciatic nerve resection in the thigh: a functional evaluation. Clin Orthop 2001, 34-41.
31. Brooks AD, Gold JS, Graham D, et al.: Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status Ann Surg Oncol 2002, 9:41-47.
32. Bell RS, O'Sullivan B, Langer F, et al.: Complications and functional results after limb-salvage surgery and radiotherapy for difficult mesenchymal neoplasms: a prospective analysis Can J Surg 1989, 32:69-73.
33. Bell RS, O'Sullivan B, Davis A, et al.: Functional outcome in patients treated with surgery and irradiation for soft tissue tumors. J Surg Oncol 1991, 48:224-231.
34. Tokarek R, Bernstein E, Sullivan F, et al.: Effect of therapeutic radiation on wound healing. Clinics in Dermatology 1994, 12:57-70.
35. Wilson AN, Davis A, Bell R, et al.: Local control of soft tissue sarcoma of the extremity: the experience of a multi-disciplinary sarcoma group with definitive surgery and radiotherapy Eur J Cancer 1994, 30A:746-751.
36. Ngan SY. Radiotherapy in soft tissue sarcoma of the extremities. Acta Orthop Scand Suppl 1997, 273:112-116.
37. Nielsen OS, Cummings B, O'Sullivan B, et al.: Preoperative and postoperative irradiation of soft tissue sarcomas: effect of radiation field size. Int J Radiat Oncol Biol Phys 1991, 21:1595-1599.
38. Cheng EY, Dusenbery KE, Winters MR, Thompson RC: Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol 1996, 61:90-99.
39. Karasek K, Constine LS, Rosier R: Sarcoma therapy: functional outcome and relationship to treatment parameters. Int J Radiat Oncol Biol Phys 1992, 24:651-656.
40. Holt G, Wunder J, Griffin A, Bell R: Fractures following radiation therapy and limb salvage surgery for soft tissue sarcomas: high versus low dose radiotherapy. Proc Musculoskeletal Tumor Soc 2002, 41:
41. Peat BG, Bell RS, Davis A, et al.: Wound-healing complications after soft-tissue sarcoma surgery. Plast Reconstr Surg 1994, 93:980-987.
42. Bujko K, Suit HD, Springfield DS, Convery K: Wound healing after preoperative radiation for sarcoma of soft tissues. Surg Gynecol Obstet 1993, 176:124-134.
43. Saddegh MK, Bauer HC: Wound complication in surgery of soft tissue sarcoma. Analysis of 103 consecutive patients managed without adjuvant therapy. Clin Orthop 1993, 247-253.
44. Skibber JM, Lotze MT, Seipp CA, et al.: Limb-sparing surgery for soft tissue sarcomas: wound related morbidity in patients undergoing wide local excision. Surgery 1987, 102:447-452.
45. Quill G, Gitelis S, Morton T, Piasecki P: Complications associated with limb salvage for extremity sarcomas and their management Clin Orthop 1990, 242-250.
46. O'Sullivan B, Davis AM, Turcotte R, et al.: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002, 359:2235-2241.
47. O'Sullivan B, Davis A: A Randomized Phase III trial of pre-operative compared to post-operative radiotherapy in extremity soft tissue sarcoma. Proceedings of the 43rd Annual Meeting American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 2001, 51(Suppl 1):151-152.
48. Yang JC, Chang AE, Baker AR, et al.: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998, 16:197-203.
49. Ferguson PC, Boynton EL, Wunder JS, et al.: Intradermal injection of autologous dermal fibroblasts improves wound healing in irradiated skin. J Surg Res 1999, 85:331-338.
50. Dantzer D, Ferguson P, Hill RP, et al.: Effect of radiation and cell implantation on wound healing in a rat model. J Surg Oncol 2003, 83:185-190.
51. Rosenblatt E, Meushar N, Bar-Deroma R, et al.: Interstitial brachytherapy in soft tissue sarcomas: the Rambam experience Isr Med Assoc J 2003, 5:547-551.
52. Pisters PW, Harrison LB, Leung DH, et al.: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996, 14:859-868.
53. Antman K, Suit H, Amato D, et al.: Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups. J Clin Oncol 1984, 2:601-608.
54. Lerner HJ, Amato DA, Savlov ED, et al.: Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol 1987, 5:613-617.
55. Alvegard TA, Sigurdsson H, Mouridsen H, et al.: Adjuvant chemotherapy with doxorubicin in high-grade soft-tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989, 7:1504-1513.
56. Gherlinzoni F, Bacci G, Picci P, et al.: A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. J Clin Oncol 1986, 4:552-558.
57. Rosenberg SA, Tepper J, Glatstein E, et al.: Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer 1983, 52: 24-434.
58. Chang AE, Kinsella T, Glatstein E, et al.: Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol 1988, 6:1491-1500.
59. Bramwell V, Rouesse J, Steward W, et al.: Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma - reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994, 12:1137-1149.
60. Frustaci S, Gherlinzoni F, De Paoli A, et al.: Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001, 19:1238-1247.
61. Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997, 350:1647-1654.
62. Zagars GK, Ballo MT, Pisters PW, et al.: Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:739-747.
63. Spillane AJ, Fisher C, Thomas JM: Myxoid liposarcoma - the frequency and the natural history of nonpulmonary soft tissue metastases Ann Surg Oncol 1999, 6:389-394.
64. Temple LK, Brennan MF: The role of pulmonary metastasectomy in soft tissue sarcoma. Semin Thorac Cardiovasc Surg 2002, 14:35-44.
65. Bramwell V, Anderson D, Charette M: Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma 2000, 4:103-112.
66. Edmonson JH, Ryan LM, Blum RH, et al.: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993, 11:1269-1275.
67. Santoro A, Tursz T, Mouridsen H, et al.: Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995, 13:1537-1545.
68. Tavani A, Pregnolato A, Negri E, et al.: Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 1997, 27:256-260.
69. Tavani A, Soler M, LaVecchia C, et al.: Body weight and risk of soft-tissue sarcoma. Br J Cancer 1999, 81: 90-892.
70. Hoppin J, Tolbert P, Herrick R, et al.: Occupational chlorophenol exposure and soft tissue sarcoma risk among men aged 30-60 years. Am J Epidemiol 1998, 148:693-703.
71. Viel J, Arveux P, Baverel J, Cahn J: Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. Am J Epidemiol 2000, 152:13-19.
72. van Oosterom AT, Judson I, Verweij J, et al.: Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 2001, 358:1421-1423.
73. Heinrich M, Corless C, Blanke C, et al.: KIT mutational status predicts clinical response to STI571 in patients with metastatic gastrointestinal stromal tumors. Prog Proc Am Soc Clin Oncol 2002, 21:2a.
74. Sirvent N, Maire G, Pedeutour F: Genetics of dermato-fibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 2003, 37:1-19.
75. Rubin BP, Schuetze SM, Eary JF, et al.: Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 2002, 20:3586-3591.
76. Borden EC, Baker LH, Bell RS, et al.: Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 2003, 9:1941-1956.